Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.
Paula AzorinFlorian BoninZakia TariqAmbre PetitalotFlorence CoussyElisabetta MarangoniVeronique BecetteYves DenouxAnne Vincent-SalomonChristophe Le TourneauLinda Larbi CherifJerzy KlijanienkoMaud KamalIvan BiècheRosette LidereauKeltouma DriouchPublished in: Clinical and translational medicine (2022)